Treatment of moderate-to-severe vasomotor symptoms associated with menopause. Prevention of postmenopausal osteoporosis.
Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Treatment of patients with previously untreated chronic lymphocytic leukemia (CLL), in combination with chlorambucil.
As a component of a combination antiviral treatment regimen for chronic hepatitis C (CHC) genotype 1, 2, 3, or 4 infection.
Chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin in patients with compensated liver disease.
Adjunctive treatment of partial-onset seizures with or without secondarily generalized seizures in patients ≥12 years of age.
Treatment of adults with major depressive disorder (MDD).